EUVIMEDEUVIMED entdecken
Crossref

Health-Related Complications during Follow-Up and Their Impact on Blood Cancer Survivors: Results from the “Aftercare in Blood Cancer Survivors” (ABC) Study

Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen

Acta Haematologica · 2024

DOI: 10.1159/000536155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Haematologica, 2024. Verfasst von Julia Baum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Cancer Survivors, Hematologic Neoplasms. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Blood cancer survivors are at increased risk for medical complications.

Methods

Our questionnaire-based study involved 1,551 blood cancer survivors with a ≥3-year interval since the last intense treatment. Its goal was to quantify health-related complications during follow-up and assess their impact on the patients’ lives.

Results

A total of 20.4% of the responding survivors reported a disease relapse, most often in indolent lymphomas. Second primary malignancies occurred in 14.1%, primarily in lymphoma and allogeneic transplantation survivors. The most frequent malignancy was basal cell carcinoma of the skin, but myeloid malignancies, melanoma, bladder, head-and-neck, and thyroid cancer also appeared disproportionately frequent. An increased infection rate was reported by 43.7%, most often after allogeneic transplantation. New cardiovascular diseases were reported by 30.2%, with a high rate of thromboembolic events in multiple myeloma (MM) and myeloproliferative diseases. Polyneuropathies were reported by 39.1%, most often by survivors with a history of MM or aggressive lymphoma. Disease relapse was perceived as the highest burden, followed by second primary malignancy, increased infection frequency, and polyneuropathy. In each area investigated, the range of perceived severities was wide.

Conclusions

Health-related complications are frequent during blood cancer follow-up, with significant repercussions on the patients’ lives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsHematologic NeoplasmsHumansMaleMiddle AgedFemaleFollow-Up StudiesAdultAgedSurveys and QuestionnairesNeoplasms, Second PrimaryAftercare

Stichwörter der Autor:innen

Blood cancerFollow-up careInfectionRelapseSecond primary malignancy

Autor:innen und Institutionen

  • Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.
  • Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany.
  • Klinik für Knochenmarktransplantation, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.

Zitieren

APA

Baum, J., Lax, H., Lehmann, N., Merkel-Jens, A., Beelen, D. W., Jöckel, K. H., & Dührsen, U. (2024). Health-Related Complications during Follow-Up and Their Impact on Blood Cancer Survivors: Results from the “Aftercare in Blood Cancer Survivors” (ABC) Study. Acta Haematologica. https://doi.org/10.1159/000536155

Vancouver

Baum J, Lax H, Lehmann N, Merkel-Jens A, Beelen DW, Jöckel KH, et al. Health-Related Complications during Follow-Up and Their Impact on Blood Cancer Survivors: Results from the “Aftercare in Blood Cancer Survivors” (ABC) Study. Acta Haematologica. 2024. doi:10.1159/000536155

BibTeX
@article{Baum2024,
  author = {Baum, Julia and Lax, Hildegard and Lehmann, Nils and Merkel-Jens, Anja and Beelen, Dietrich W and Jöckel, Karl-Heinz and Dührsen, Ulrich},
  title = {Health-Related Complications during Follow-Up and Their Impact on Blood Cancer Survivors: Results from the “Aftercare in Blood Cancer Survivors” (ABC) Study},
  journal = {Acta Haematologica},
  year = {2024},
  doi = {10.1159/000536155}
}
Kostenlos starten →